Neuland Laboratories Ltd. (NEULANDLAB) Share Price Falls 3.77% Today

Neuland Laboratories Ltd. Share Price fell 3.77% today to Rs 18,973.15, with a market cap of Rs 24,196.91 crore.

Neuland Laboratories Ltd. Share Price experienced a notable decline today, falling by 3.77% to close at Rs 18,973.15. This drop in share price positions the company within the large-cap category, with a market capitalisation of Rs 24,196.91 crore. While the data confirms the price event, it does not establish a company-specific catalyst for this decline. Investors and analysts are likely to scrutinize the factors contributing to this price action, including technical and fundamental indicators, to better understand the market dynamics affecting Neuland Laboratories Ltd.

Neuland Laboratories Ltd. (NEULANDLAB) Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 18,973.15
Previous Close	Rs 19,716.3
Today's Change	Rs -743.15 (-3.77%)
Day Open	Rs 19,700.05
Day High	Rs 19,700.05
Day Low	Rs 18,950
Current Volume (BSE)	3,452
BSE Traded Volume	3,452
NSE Traded Volume	21,151
Combined NSE + BSE Volume	24,603
Turnover	Rs 6.55 crore
Market Capitalisation	Rs 24,196.91 crore
Market Cap Category	Large Cap

Neuland Laboratories Ltd. (NEULANDLAB) traded at Rs 18,973.15. versus the previous close of Rs 19,716.3, a fall of 3.77%. The stock opened at Rs 19,700.05, reached Rs 19,700.05, touched Rs 18,950. Reported volume was 3,452.

Neuland Laboratories Ltd. (NEULANDLAB) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 24,196.91 crore

Neuland Laboratories Ltd. operates within the healthcare sector, with a market capitalisation of Rs 24,196.91 crore. The company's valuation metrics, such as P/E, P/B, and EV/EBITDA, are crucial for understanding its financial health and market positioning. The sector's benchmark data provides a comparative framework, with the median P/E at 26.56 and the average at 87.07. Neuland Laboratories Ltd.'s market cap is significantly higher than the sector's median of Rs 138.42 crore, indicating its substantial presence in the market. The company's performance metrics, including ROE and ROCE, are essential for assessing its profitability and efficiency in capital utilisation. These fundamentals, combined with the sector's performance, offer insights into the company's valuation and potential areas of interest for investors.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Benchmark Scope	same sector
Benchmark Median P/E	26.56x
Benchmark Average P/E	87.07x
Benchmark P/E Range	3.47x to 3,385.56x
Benchmark Median P/B	1.91x
Benchmark Median ROE	10.74%
Benchmark Median ROCE	13.24%
Company Market Capitalisation	Rs 24,196.91 crore
Benchmark Median Market Cap	Rs 138.42 crore

Neuland Laboratories Ltd. (NEULANDLAB) is classified under sector: Healthcare.

Track today's top decliners through the Univest top decliners screener. The peer table below provides the company-level comparison.

Neuland Laboratories Ltd. is part of the healthcare sector, which comprises 198 companies. The sector's P/E ratio ranges from 3.47 to 3385.56, with a median of 26.56. The company's valuation metrics are compared against these benchmarks to assess its market position. The sector's P/B ratio ranges from -16.48 to 16.71, with a median of 1.91. Neuland Laboratories Ltd.'s market capitalisation of Rs 24,196.91 crore is significantly above the sector's median, highlighting its substantial market presence. The sector's ROE and ROCE averages are 15.15% and 17.62%, respectively, providing a benchmark for evaluating the company's profitability and capital efficiency. These sector insights are crucial for understanding the broader market dynamics and the company's relative performance.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Dishman Carbogen Amcis Ltd.	DCAL	2,856.59	30.28	0.44	-2.89	-0.26
Kwality Pharmaceuticals Ltd.	KPL	2,686.76	40.11	8.17	28.21	26.35
Hikal Ltd.	HIKAL	2,676.24	0	2.27	15.22	16.15
Panacea Biotec Ltd.	PANACEABIO	2,540.37	0	3.11	0	5.36
Solara Active Pharma Sciences Ltd.	SOLARA	2,446.19	0	1.91	17.23	15.34

Neuland Laboratories Ltd. (NEULANDLAB) has a market capitalisation of Rs 24,196.91 crore. Among the 5 peers shown, 0 have a larger market capitalisation.

In the healthcare sector, Neuland Laboratories Ltd. competes with several peers, including Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., and Hikal Ltd. These companies vary in market capitalisation, P/E, P/B, ROE, and ROCE metrics. For instance, Dishman Carbogen Amcis Ltd. has a market cap of Rs 2,856.59 crore and a P/E of 30.28, while Kwality Pharmaceuticals Ltd. has a market cap of Rs 2,686.76 crore and a P/E of 40.11. These comparisons provide insights into Neuland Laboratories Ltd.'s competitive positioning and valuation relative to its peers.

Why Investors Are Watching Neuland Laboratories Ltd.

Investors are closely monitoring Neuland Laboratories Ltd. due to its significant price fall and market position. The company's performance in the healthcare sector, combined with its valuation metrics and peer comparisons, offers a comprehensive view of its market dynamics.

• Price action: 3.77% decline today.
• Technical position: Analysis pending due to data limitations.
• Fundamental context: Strong market cap and sector presence.
• Sector positioning: Significant market presence in healthcare.

Investors should continue to monitor the company's performance and market conditions to better understand its potential trajectory and investment opportunities.

About Neuland Laboratories Ltd.

Neuland Laboratories Ltd. is a prominent player in the healthcare sector, focusing on pharmaceuticals and drugs. The company operates in various segments, providing a range of products and services within the industry. Its substantial market capitalisation reflects its significant presence and influence in the market. As a key player in the healthcare sector, Neuland Laboratories Ltd. is involved in the development, manufacturing, and marketing of pharmaceutical products, catering to a diverse clientele. The company's strategic positioning and operational capabilities make it a noteworthy entity in the industry.

Track Neuland Laboratories Ltd. Share Price on Univest

Use Neuland Laboratories Ltd. (NEULANDLAB) live share-price page, Univest top decliners screener, Univest market blogs to review live stock data, top decliners lists and related market analysis.

Investors and analysts can track Neuland Laboratories Ltd. Share Price on Univest for real-time updates and insights. Univest provides comprehensive data on share prices, technical indicators, fundamental ratios, shareholding patterns, 52-week levels, and market insights, enabling informed decision-making and analysis.

Frequently Asked Questions

What was Neuland Laboratories Ltd. Share Price today?

Ans. Neuland Laboratories Ltd. Share Price closed at Rs 18,973.15 today, marking a 3.77% decline from the previous close of Rs 19,716.3. The stock moved -3.77% during the session. The intraday range extended from Rs 18,950 to Rs 19,700.05.

How much did Neuland Laboratories Ltd. Share Price fall today?

Ans. Neuland Laboratories Ltd. Share Price fell by Rs 743.15 today, representing a 3.77% decrease from the previous close. The stock moved -3.77% during the session. The intraday range extended from Rs 18,950 to Rs 19,700.05.

How does Neuland Laboratories Ltd.'s P/E compare to the sector median?

Ans. The sector median P/E is 26.56, providing a benchmark for evaluating Neuland Laboratories Ltd.'s valuation. The relevant peer median P/E is 26.56x. The peer average P/E is 87.07x. The stock belongs to the Healthcare sector.

Who are Neuland Laboratories Ltd.'s peers?

Ans. Neuland Laboratories Ltd.'s peers include Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., and Hikal Ltd., among others. Comparable listed companies include Dishman Carbogen Amcis Ltd., Kwality Pharmaceuticals Ltd., Hikal Ltd.

What is the sector's average ROE?

Ans. The sector's average ROE is 15.15%, providing a benchmark for assessing company profitability. The relevant peer median ROE is 10.74%. The relevant peer median ROCE is 13.24%. The stock belongs to the Healthcare sector.

What is the sector's average ROCE?

Ans. The sector's average ROCE is 17.62%, offering a benchmark for evaluating capital efficiency. The relevant peer median ROE is 10.74%. The relevant peer median ROCE is 13.24%. The stock belongs to the Healthcare sector.

What is the sector's market cap range?

Ans. The sector's market cap ranges from Rs 4.96 crore to Rs 2,856.59 crore, with a median of Rs 138.42 crore. The company operates in the Healthcare sector. The stock belongs to the Healthcare sector.